Short Interest in Nukkleus Inc. (NASDAQ:DFNS) Decreases By 48.2%

Nukkleus Inc. (NASDAQ:DFNS) was the recipient of a significant decline in short interest during the month of August. As of August 14th, there was short interest totaling 144,490 shares, a decline of 48.2% from the July 30th total of 279,125 shares. Currently, 16.1% of the shares of the stock are sold short. Based on an average trading volume of 2,406,740 shares, the short-interest ratio is currently 0.1 days.

Nukkleus Price Performance

NASDAQ DFNS traded down $0.52 during trading hours on Friday, hitting $12.19. 577,571 shares of the company’s stock traded hands, compared to its average volume of 2,418,921. The company has a market capitalization of $12.31 million, a PE ratio of -0.03 and a beta of -5.80. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.14 and a quick ratio of 0.11. Nukkleus has a 52-week low of $3.70 and a 52-week high of $1,948.75. The firm’s 50-day moving average is $23.58 and its 200-day moving average is $81.54.

Nukkleus (NASDAQ:DFNS) last released its earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.11) by ($170.69). The business had revenue of $4.00 million for the quarter, compared to analyst estimates of $4.50 million. Equities analysts forecast that Nukkleus will post -3.9 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

DFNS has been the subject of several research reports. Wall Street Zen upgraded Nukkleus from a “strong sell” rating to a “sell” rating in a research report on Sunday, August 23rd. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. Finally, Weiss Ratings cut shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Nukkleus currently has a consensus rating of “Moderate Buy”.

Hedge Funds Weigh In On Nukkleus

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. LPL Financial LLC purchased a new stake in Nukkleus in the 4th quarter valued at $120,000. Geode Capital Management LLC raised its holdings in shares of Nukkleus by 193.7% during the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock worth $503,000 after acquiring an additional 82,252 shares during the period. Ausdal Financial Partners Inc. purchased a new position in shares of Nukkleus during the 3rd quarter worth $105,000. UBS Group AG boosted its position in shares of Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after acquiring an additional 15,223 shares during the last quarter. Finally, Millennium Management LLC acquired a new position in shares of Nukkleus during the 4th quarter valued at about $60,000. Institutional investors and hedge funds own 12.47% of the company’s stock.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.